More Popular Issues
See how voters are siding on other popular political issues...
Results from Doctorate Degree voters
Last answered 4 minutes ago
Distribution of answers submitted by Doctorate Degree voters.
Data includes total votes submitted by visitors since Jan 17, 2017. For users that answer more than once (yes we know), only their most recent answer is counted in the total results. Total percentages may not add up to exactly 100% as we allow users to submit "grey area" stances that may not be categorized into yes/no stances.
Choose a demographic filter
* Data estimated by matching users to U.S. Census data block groups via the American Community Survey (2007-2011)
Learn more about Medicare Drug Prices
The government is currently prohibited by law from negotiating drug prices for Medicare. Medicare Part D is a federal government program which subsidizes the costs of prescriptions drugs for people enrolled in Medicare. Since it was approved by Congress in 2003 39 million Americans have enrolled in the program which now costs more than $80 billion per year. Opponents of Medicare Part D argue that it should be changed to allow the federal government to negotiate prices with pharmaceutical companies. They point out that the Veterans Affairs administration is allowed to negotiate prices and pays 40-58% less for drugs than Medicare does. Analysts estimate that the government would save up to $16 billion a year if they were permitted to negotiate drug prices. Proponents of Medicare D argue that the government should not interfere with prices set by private drug makers who use profits for the development and research of new drugs. See recent Medicare Drug Prices news